Medical devices, healthcare technology and the business of care
PMA approval · P950022

TVL(TM) LEAD SYSTEM

ABBOTT MEDICAL · Decision date May 10, 1996

MEDTECHLEDGER EXPLANATIONP950022

What did the FDA approve?

The FDA recorded approval of P950022, the Ventritex TVL Lead System, on 1996-05-10 under product code LWS in the cardiovascular specialty, with Abbott Medical listed as applicant. The recorded scope covers transvenous right ventricular leads (RV-1101, RV01, RV02), transvenous superior vena cava leads (SV-1101, SV01, SV02, SV03), subcutaneous leads (SQ-701, SQ01), a vein pick (TV-0001), silicone lubricant (TV-0013), a lead tunneler kit (LTK-01), a high voltage Y-adapter (AC-2481), an external stimulator adapter (AC-CDT-EX), and an accessory kit.

This is an original approval rather than a supplement, so the record describes the lead system and its accessories as a category; patient-selection criteria and treatment instructions are not part of the source data and remain in the original FDA document. The record does not state current labeling, post-market findings, or the basis for the decision.

FDA approval order statement

APPROVAL FOR THE VENTRITEX TVL LEAD SYSTEM:TRANSVENOUS RIGHT VENTRICULAR LEAD MODELS RV-1101, RV01, AND RV02; TRANSVENOUS SUPERIOR VENA CAVA LEAD MODELS, SV-1101, SV01, SV02, AND SV03; SUBCUTANEOUS LEAD MODELS, SQ-701 AND SQ01; VEIN PICK MODEL TV-0001; SILICONE LUBRICANT MODEL TV-0013; LEAD TUNNELER KIT MODEL LTK-01; MODEL AC-2481 HIGH VOLTAGE Y-ADAPTER; MODEL AC-CDT-EX VENTRITEX EXTERNAL STIMULATOR ADAPTER; AND TVL LEAD SYSTEM ACCESSORY KIT
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
May 10, 1996

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P950022
Regulatory pathway
Premarket approval application
Product code
LWS
Decision code
APPR
Decision date
May 10, 1996
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable cardioverter defibrillator (non-CRT).

Product code
LWS
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P950022 received

    Application receipt date recorded by FDA.

  2. P950022 · FDA decision

    APPR

  3. P950022/S153 · Related supplement

    UltiSynq Defibrillation lead; SurGrip Suture Sleeve Accessory

Timeline entries are records held by MedtechLedger for P950022. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P950022

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementNov 5, 2026FDA

Explore the linked device profile

Other records with product code LWS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
15900 Valley View Ct., Sylmar, CA, 91335

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records